Literature DB >> 3456269

Purification of stable protein kinase C from mouse brain cytosol by specific ligand elution using fast protein liquid chromatography.

A Y Jeng, N A Sharkey, P M Blumberg.   

Abstract

The Ca2+- and phospholipid-dependent protein kinase (protein kinase C) has been purified to electrophoretic homogeneity from mouse brain cytosol. [20-3H]phorbol 12,13-dibutyrate binding activity was found to coelute quantitatively with the protein kinase activity throughout the purification procedure. The crude extract was first run over a DE52 column. Fractions containing peak activities were then chromatographed using a fast protein liquid chromatography system with a Mono Q column followed by chromatography on the same column run in the presence of 1 mM adenosine triphosphate. The adenosine triphosphate specifically shifted the elution position of the Ca2+- and phospholipid-dependent protein kinase, providing a powerful step in the purification procedure. The remaining minor contaminants were removed by hydrophobic chromatography on a TSK-phenyl-5-PW column. This purification procedure required less than 2 days after the initial large batch DE52 column chromatography. The molecular weight of the purified receptor was estimated to be 81,000 by its mobility on sodium dodecyl sulfate/polyacrylamide gels, in agreement with the published values. Optimal conditions for the storage of the purified receptor were sought. Both protein kinase and phorbol ester binding activities were stable for 2 mo when stored in the presence of 0.01% Triton X-100 at -70 degrees C. Polyclonal antibodies to the purified receptor have been prepared from rabbits. These antibodies recognized the purified receptor in electroblotting assays and were able to immunoprecipitate the purified receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456269

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs.

Authors:  P A Wender; K F Koehler; N A Sharkey; M L Dell'Aquila; P M Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Protein kinase C inhibitors prevent induction and continued expression of cell memory in Hermissenda type B photoreceptors.

Authors:  J Farley; E Schuman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Protein kinase C phosphorylation of thymus myosin.

Authors:  A G Carroll; P D Wagner
Journal:  J Muscle Res Cell Motil       Date:  1989-10       Impact factor: 2.698

4.  Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes.

Authors:  S M Pitson; R J D'andrea; L Vandeleur; P A Moretti; P Xia; J R Gamble; M A Vadas; B W Wattenberg
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

5.  Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function.

Authors:  J C Hsieh; P W Jurutka; M A Galligan; C M Terpening; C A Haussler; D S Samuels; Y Shimizu; N Shimizu; M R Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

Authors:  P A Wender; C M Cribbs; K F Koehler; N A Sharkey; C L Herald; Y Kamano; G R Pettit; P M Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.

Authors:  P J Silver; M J Connell; K M Dillon; W R Cumiskey; W A Volberg; A M Ezrin
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.